Mode
Text Size
Log in / Sign up

Piperacillin treatment resolves symptoms and normalizes inflammatory markers in a case of prostatic malakoplakiaPiperacillin Treatment Shows Promise for Prostate Malakoplakia Cases

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Recognize that prostatic malakoplakia can mimic prostate cancer on imaging and PSA, requiring histopathology for diagnosis.

This publication combines a case report of a 64-year-old male with a narrative literature review of 90 cases of prostatic malakoplakia. The case report describes a patient presenting with gross hematuria, frequency, and urgency, with a serum PSA of 8.72 ng/mL and an mpMRI PI-RADS score of 4. Histopathology confirmed the presence of histiocytes containing Michaelis-Gutmann (MG) bodies.

Following treatment with piperacillin sodium, the patient experienced complete resolution of symptoms and normalization of both inflammatory markers and PSA at one month. The accompanying narrative review of 90 cases indicates that antibiotic therapy appears effective in most reported cases and that the prognosis for patients with prostatic malakoplakia is generally favorable.

Clinical utility is noted as prostatic malakoplakia can mimic prostate cancer on PSA and mpMRI. However, definitive diagnosis requires the pathological identification of MG bodies. The evidence is limited by the small sample size of the primary case report and the narrative nature of the literature review.

How this fits prior evidence

This finding addresses a gap in clinical differentiation by highlighting that prostatic malakoplakia can mimic prostate cancer on PSA and mpMRI. While other covered evidence discusses advanced treatments like apalutamide plus ADT or imaging modalities like PSMA PET-CT for prostate cancer, this report identifies a specific condition that may mimic malignancy and respond to antibiotic therapy.

Prostatic malakoplakia is a rare condition that can be difficult to identify because it often looks like prostate cancer on imaging tests. In one case involving a 64-year-old man, the patient presented with blood in the urine and elevated inflammatory markers. An MRI showed a PI-RADS score of 4, which often suggests a need for further investigation. However, a biopsy confirmed the presence of Michaelis-Gutmann bodies, which are the hallmark of malakoplakia.

The patient was treated with piperacillin. After one month, his symptoms resolved completely, and his inflammatory markers and PSA levels returned to normal. This specific case highlights how the condition can mimic more common cancers on initial tests.

A review of 90 other cases suggests that antibiotic therapy is generally effective for this condition and leads to a favorable outlook. Because this is based on a single case report and a narrative review of 90 cases, the evidence is limited. These findings are helpful for doctors trying to distinguish this condition from cancer, but you should speak with a healthcare provider for any specific medical concerns.

What this means for you:
Antibiotics like piperacillin may effectively treat prostatic malakoplakia, which can mimic prostate cancer on scans.

Common questions

What is prostatic malakoplakia?

Prostatic malakoplakia is a rare condition that can appear on imaging tests like an mpMRI as a PI-RADS score of 4. Because it can mimic prostate cancer on PSA tests and scans, a biopsy is often needed to find specific markers called Michaelis-Gutmann bodies to confirm the diagnosis.

How was the patient treated in this case?

In the reported case, a 64-year-old man was treated with piperacillin. After one month of treatment, his symptoms resolved completely, and his inflammatory markers and PSA levels returned to normal. A review of 90 other cases also suggests that antibiotic therapy is generally effective for this condition.

Is this a common way to treat prostate issues?

While antibiotic therapy appears effective for malakoplakia, this specific condition is rare. Because the evidence comes from a single case report and a narrative review of 90 cases, it is not a standard treatment for all prostate issues. You should consult a doctor to discuss your specific results.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
Malakoplakia is an extremely rare chronic inflammatory disorder, most commonly affecting the genitourinary tract. Prostatic malakoplakia is particularly uncommon. Its elevated serum prostate-specific antigen (PSA) levels, magnetic resonance imaging (MRI) findings, and clinical symptoms closely mimic those of prostate cancer, leading to a high risk of misdiagnosis. Here we report a 64-year-old male patient presenting with gross hematuria, frequency, and urgency. Laboratory tests revealed elevated inflammatory markers and a serum PSA of 8.72 ng/mL. Multiparametric MRI (mpMRI) showed a Prostate Imaging Reporting and Data System (PI-RADS) score of 4, raising high suspicion of prostate cancer. Transrectal ultrasound-guided prostate biopsy was performed. Histopathology showed diffuse infiltration by histiocytes containing characteristic Michaelis-Gutmann (MG) bodies with typical morphological features on hematoxylin and eosin (H&E) staining. Immunohistochemistry confirmed prostatic malakoplakia and ruled out malignancy. After treatment with piperacillin sodium, the patient’s symptoms resolved completely. Follow-up at one month showed normalization of inflammatory markers and PSA. This article also narrative literature review 90 cases reported in the past 30 years, summarizing the clinical presentation, imaging features, pathological characteristics, diagnosis, differential diagnosis, and treatment strategies for prostatic malakoplakia. In patients with elevated PSA and mpMRI findings suspicious for prostate cancer, if the lesion shows diffuse symmetric distribution, an intact capsule, and delayed periprostatic enhancement, prostatic malakoplakia should be included in the differential diagnosis. Definitive diagnosis depends on pathological identification of MG bodies. Antibiotic therapy appears to be effective in most reported cases, and the prognosis is generally favorable.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.